Cardiovascular
Services
Home
Your Heart & Heart Disease
The Healthy Heart
Cardiac Disorders
Prevention
Treatment
Medications
Interventional Cardiology
Surgery
Cardiac Rehabilitation
About the Institute
Meet the
Cardiac Services Staff
Meet the
Cardiothoracic Staff
Directions
Contact Us
NJCITreatmentInterventional Cardiology Printer Friendly Page
Angioplasty

   

Angioplasty, also known as percutaneous transluminal coronary angioplasty (PTCA), is a technique for opening blocked arteries and treating coronary artery disease. It is a relatively low risk, low cost, non-surgical treatment.

To restore normal blood flow, a balloon-tipped catheter is inserted into the clogged artery, and is then inflated. The inflated balloon compresses the plaque against the artery wall, making more room for blood to flow. The balloon is then deflated and removed. Opening the artery will not result in a completely plaque free artery, but the plaque will be compressed so blood can pass through the vessel.

In order to keep the plaque from closing the artery again, a coronary stent may be used to hold the plaque in place. The stent is a metal mesh tube that is placed at the blockage site during angioplasty.

In approximately 20 to 25 percent of stents, scar tissue may develop around the area of the stent, causing restenosis - (a new blockage) within six months of treatment. If this occurs, the doctor can reopen the vessel by angioplasty and then use vascular brachytherapy to prevent another blockage.

Recent developments in stent technology have included the drug-eluting (drug-coated) stent. The drug-eluting stent is coated with a drug, Sirolimus, that is released over time. The drug inhibits the development of scar tissue around the area of the formerly blocked artery, reducing reocclusion to approximately 5 percent.

There have been some concerns by consumers and the media about risks associated with the drug-eluting stent. The consensus from the medical community is that if drug-eluting stent recipients receive a prescription platelet inhibitor medication for six months following the placement of the stent, the risks are minimized. Plavix or, in some cases Ticlid, is prescribed.

How is a Coronary Stent Implanted?

 

Distal Protection

 
 
   

Distal Protection is also known as temporary balloon occlusion and aspiration, and is a relatively new treatment for opening occluded coronary bypass vessels. Coronary bypass surgery provides a new pathway for blood to travel through the heart. A vein from the leg, known as a saphenous vein, is removed and grafted between the aorta and the blocked artery providing an alternate route for blood to flow. Many times, an aging saphenous vein itself becomes blocked; this typically happens between 10-15 years (50 percent are blocked by the 10 year mark) after the original graft. When angioplasty is used to open these blockages, tiny particles can break off the arterial wall and be carried further down the artery causing an occlusion of the vessel at another location. Between 10 and 20 percent of the time, this "debris" causes serious problems-- namely, a heart attack.

Distal protection substantially minimizes the risk of floating debris which can break off during angioplasty. Working from outside the body through a small incision in the patient's groin, the physician maneuvers a thin, hollow tube (about .014 of an inch in diameter) into the blocked saphenous vein graft vessel. The tube carries a net-like mechanism at its tip (figure 1) that is opened to catch any floating debris (figure 2).

The physician then performs an angioplasty/stent procedure. The debris particles are caught in the net. The net is then closed with the debris still inside it and removed (figure 3).

Combined tPA Therapy

The clot busting drug tPA has been used for many years as a treatment following heart attacks, and more recently in the treatment of strokes. Now, recent studies suggest that the use of very low doses of tPA combined with balloon angioplasty is a highly effective treatment option. Using tPA, studies suggest, is not only cost effective, but may even allow doctors to salvage highly diseased arteries.

Implantable cardioverter defibrillator (ICD)

Similar to a pacemaker, a battery-operated ICD is implanted in the body and contains a microprocessor and has wires connected to the heart to monitor and record heart rate. The ICD delivers potentially life-saving electrical shocks to counteract lethal arrhythmias. These devices may also be used for patients with certain types of tachycardia (heart beats too fast).

Pacemakers

A pacemaker signals the heart to beat when it is too slow. It is made up of an electrical-pulse generator and one-two wires, which deliver electrical impulses to the heart. The wires can also carry signals from the heart. The pulse generator interprets these signals, determines the heart's activity and responds to its needs.

Radiofrequency Ablation

Another option for some arrhythmia patients, that is up to 95 percent effective. Ablation means "elimination," and that's what this technique does to tissue involved in certain types of arrhythmia. As with an electrophysiology study, radiofrequency ablation involves the threading of electrode catheters, guided by x-ray, into the heart. The electrophysiologist "maps" the electrical signals and locates the arrhythmia source. Then, radiofrequency energy (electromagnetic radio waves) is directed to that precise spot, destroying the tissue and, thus, permanently ending the arrhythmic episodes.

Return to Top Printer Friendly Page